前列腺癌SBRT中间隔水凝胶形态的次间监测
本研究纳入198例在前列腺SBRT前接受间隔水凝胶并通过MR-Linac治疗的患者,利用U-Net深度学习模型纵向监测水凝胶形态变化。结果显示水凝胶整体几何形态在5次分次治疗中保持稳定,无显著吸收证据,但平坦度指标轻微增加,且治疗影像中水凝胶体积平均增加10.62%。
要点
- 水凝胶整体几何形态在5次SBRT分次中保持稳定。
- 平坦度每10天增加0.003单位,形状略变圆。
- 治疗影像中水凝胶体积平均增加10.62%。
核心结论
- 水凝胶在前列腺SBRT的5次分次治疗中保持直肠保护构型,整体几何形态稳定。
研究设计与样本
- 单中心研究纳入2023年10月至2025年3月接受前列腺SBRT的198例患者,每例至少1次模拟MRI和5次治疗中MRI。
- 使用nnUNetv2构建U-Net深度学习模型,迭代训练后Dice相似系数>0.98,用于检测水凝胶形态随时间的变化。
主要发现
- 纵向建模显示平坦度变化具有统计学意义,每10天增加0.003单位(95%CI 0.001-0.005;FDR q≈0.02),提示形状逐渐变圆。
- 治疗影像中水凝胶体积平均增加10.62%(95%CI 8.68%-12.56%;P<.001),绝对体积差为1.19 cm³(95%CI 1.00 cm³-1.39 cm³;P<.001)。
- 其他影像组学形状特征变化微小或不一致。
关键数值与推荐
- 模拟定位与首次治疗平均间隔约19.9天,与末次治疗平均间隔约31.1天,治疗间间隔2至3天。
临床怎么用
- 前列腺SBRT计划假设水凝胶稳定,次间变化可能影响直肠剂量估算,需关注水凝胶形态的纵向变化。
- 本队列中水凝胶未出现有意义的吸收,直肠保护配置在整个SBRT疗程中得以维持。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study is to explore whether spacer hydrogel morphology changes during the course of stereotactic body radiation therapy (SBRT) radiation to the prostate. METHODS AND MATERIALS: A total of 198 patients at our institution each received spacer gel before SBRT on magnetic-resonance-guided linear accelerator (MR-Linac) between October 2023 and March 2025. Each patient received at least 1 simulation magnetic resonance imaging and 5 on-treatment magnetic resonance imaging scans. Average time between simulation and first treatment and between simulation and final treatment was approximately 19.9 days and 31.1 days, respectively, with 2- to 3-day intervals between treatments. A U-Net deep learning model was implemented using nnUNetv2. This model was iteratively trained using inference images, resulting in a Dice similarity coefficient >0.98, and was then applied to detect changes in gel morphology over time. RESULTS: Longitudinal modeling of spacer gel radiomic shape features demonstrated a statistically significant change in flatness that remained significant over false discovery rate correction and all sensitivity analyses. This metric increased by 0.003 units per 10 days (95% CI, 0.001-0.005; false discovery rate q ≈ 0.02), implying a progressively rounder shape over the observation period. All other features showed minimal or inconsistent change. The hydrogel appeared larger on treatment imaging, with a mean percent change of 10.62% (95% CI, 8.68%-12.56%; P < .001). The corresponding absolute volume difference was 1.19 cm³ (95% CI, 1.00 cm³-1.39 cm³; P < .001). CONCLUSIONS: Because prostate SBRT planning assumes gel stability, interfractional changes could affect rectal dose estimates. In this cohort, the spacer hydrogel's overall geometry remained stable across the 5-fraction course, with no meaningful evidence of gel resorption. A small increase in the flatness metric was observed, but without a change in size or compactness. These findings indicate that the gel maintains its rectal-sparing configuration throughout SBRT.
引用
- Koduri S, Barbee D, Oh C, et al. Interfractional Monitoring of Spacer Hydrogel Morphology in Patients With Prostate Cancer Receiving SBRT Treatment. Pract Radiat Oncol. 2026. PMID: 42565768. doi:10.1016/j.prro.2026.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。